Haemoglobinopathies congenital Completed Phase 1 Trials for Fludarabine (DB01073)

Also known as: Hemoglobinopathy / Haemoglobinopathies / Hemoglobinopathies / Haemoglobinopathy / Haemoglobinopathy NOS / Abnormal hemoglobin NOS

IndicationStatusPhase
DBCOND0026458 (Haemoglobinopathies congenital)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00744692Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant DisordersTreatment